Phibro Animal Health Corporation cash flow to debt ratio of 10.52% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Phibro Animal Health Corporation's free cash flow has decreased 9.76% from $46.36M last year to $41.83M, signaling decreasing performance

Phibro Animal Health Corporation's debt to equity ratio is 2.18, which means that the company's assets are unhealthy financed, signaling financial risk.

Phibro Animal Health Corporation's debt has increased relative to shareholder equity from 2.05 last year to 2.18 today, signaling weakened financials

Phibro Animal Health Corporation has a net debt to EBITDA ratio of 4.66x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

Phibro Animal Health Corporation's interest coverage ratio of 4.01 indicates that earnings with good margin can cover interest payments on company debt

Phibro Animal Health Corporation's profit margin has increased (2.57K%) in the last year from 0.24% to 6.35%, signaling increasing performance

Phibro Animal Health Corporation's short-term assets of $810.61M exceed its short-term liabilities of $293.47M

Phibro Animal Health Corporation's return on assets of 6.59% is higher than the 5.00% threshold, indicating efficient asset utilization

Phibro Animal Health Corporation's return on equity of 29.49%, is higher than 15.00%, indicating good performance

Phibro Animal Health Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Phibro Animal Health Corporation had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Phibro Animal Health Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Phibro Animal Health Corporation has a free cash flow yield of 3.02%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Phibro Animal Health Corporation's yearly earnings has increased 1.90K% since last year from $2.42M to $48.26M, signaling increasing performance

Phibro Animal Health Corporation's yearly revenue has increased 27.37% since last year from $1.02B to $1.30B, signaling increasing performance

ROIC 11.38% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Phibro Animal Health Corporation's 3-year revenue CAGR of 11.22% is positive, indicating growing revenue over the past 3 years

Phibro Animal Health Corporation had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Phibro Animal Health Corporation had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Phibro Animal Health Corporation is overvalued relative to its fair value price of 1.21 based on Discounted Cash Flow model

Phibro Animal Health Corporation has an earnings yield of 6.88%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Phibro Animal Health Corporation is overvalued relative to its fair value price of 8.26 based on EBITDA multiple model

Phibro Animal Health Corporation has an EV/EBITDA ratio of 14.09x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Phibro Animal Health Corporation is undervalued relative to its fair value price of 53.73 based on Earnings Fair Value model

Phibro Animal Health Corporation has a PEG-ratio over 1 which is considered overvalued

Phibro Animal Health Corporation has a price-to-book ratio of 3.83x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Phibro Animal Health Corporation has a price-to-sales ratio of 0.92x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue